Tony Chapman sat in a hospital chair being given an injection. He is wearing a dark blue shirt. A a nurse in a blue uniform is giving him an injection of either the vaccine treatment or a placebo drug.Image source, Addenbrooke's Hospital
Image caption,

Tony Chapman, 75, from Corby in the East Midlands was one of the 1,100 melanoma patients enrolled on the vaccine trial

ByJim ReedHealth reporter
  • Published24 minutes ago

A new personalised cancer vaccine given alongside a widely used immunotherapy drug has cut the risk of patients dying or their skin cancer returning by 42% in a major clinical trial.

The researchers involved say the results could mark a turning point in cancer treatment, bringing personalised medicine a step closer.